|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
EP1690868A1
(en)
|
1997-10-31 |
2006-08-16 |
Maxygen, Inc. |
Modification of virus tropism and host range by viral genome shuffling
|
|
ATE454445T1
(de)
|
1998-11-10 |
2010-01-15 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
EP1026250A1
(en)
|
1998-12-02 |
2000-08-09 |
Aventis Behring GmbH |
DNA-constructs of blood clotting factors and P-selectin
|
|
EP1010762A1
(en)
|
1998-12-02 |
2000-06-21 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
DNA constructs of blood clotting factors and P-Selectin
|
|
EP1038959A1
(en)
|
1999-03-17 |
2000-09-27 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
|
|
EP1048726B1
(en)
|
1999-04-27 |
2006-07-26 |
Négrier, Claude |
Modified factor VIII cDNA
|
|
US20020045264A1
(en)
|
2000-03-14 |
2002-04-18 |
During Matthew J. |
Production of chimeric capsid vectors
|
|
WO2002053703A2
(en)
|
2001-01-05 |
2002-07-11 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
US7749492B2
(en)
|
2001-01-05 |
2010-07-06 |
Nationwide Children's Hospital, Inc. |
AAV vectors and methods
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
CN103555677B
(zh)
|
2001-11-13 |
2018-01-30 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
WO2003052051A2
(en)
|
2001-12-17 |
2003-06-26 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) serotype 8 sequences
|
|
US7858367B2
(en)
|
2002-04-30 |
2010-12-28 |
Duke University |
Viral vectors and methods for producing and using the same
|
|
JP2007524386A
(ja)
|
2003-06-19 |
2007-08-30 |
アビジェン， インコーポレイテッド |
減少した免疫反応性を有するａａｖビリオン、およびその使用
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
DK3211085T3
(da)
|
2003-09-30 |
2021-06-21 |
Univ Pennsylvania |
Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf
|
|
WO2005072364A2
(en)
|
2004-01-27 |
2005-08-11 |
University Of Florida |
A modified baculovirus expression system for production of pseudotyped raav vector
|
|
US7892809B2
(en)
|
2004-12-15 |
2011-02-22 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
WO2006130639A2
(en)
|
2005-05-31 |
2006-12-07 |
Neurologix, Inc. |
Novel glutamic acid decarboxylase (gad) chimera and methods of use
|
|
WO2007089632A2
(en)
|
2006-01-27 |
2007-08-09 |
The University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
MX2009001875A
(es)
|
2006-08-21 |
2009-03-02 |
Genentech Inc |
Compuestos de aza-benzotiofenilo y metodos de uso de los mismos.
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
EP2623605B1
(en)
|
2007-04-09 |
2018-11-28 |
University of Florida Research Foundation, Inc. |
RAAV vector compositions having tyrosine-modified capsid proteins and methods for use
|
|
US20100203083A1
(en)
*
|
2007-05-31 |
2010-08-12 |
Medigene Ag |
Mutated structural protein of a parvovirus
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
US9464119B2
(en)
|
2009-03-04 |
2016-10-11 |
Deutsches Krebsforschungszentrum |
Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
US9169299B2
(en)
|
2011-08-24 |
2015-10-27 |
The Board Of Trustees Of The Leleand Stanford Junior University |
AAV capsid proteins for nucleic acid transfer
|
|
CN104520421B
(zh)
|
2011-10-28 |
2017-05-24 |
北卡罗来纳-查佩尔山大学 |
用于生产腺伴随病毒的细胞系
|
|
EP2900686B1
(en)
|
2012-09-28 |
2020-06-10 |
The University of North Carolina At Chapel Hill |
Aav vectors targeted to oligodendrocytes
|
|
DK2911687T3
(da)
|
2012-10-26 |
2019-05-13 |
Univ Brussel Vrije |
Vektor til levermålrettet genterapi af hæmofili og fremgangsmåder og anvendelse deraf
|
|
US10385112B2
(en)
|
2013-03-14 |
2019-08-20 |
Asklepios Biopharmaceutical, Inc. |
Modified soluble VEGF receptor-1 genes and vectors for gene therapy
|
|
CN105163764B
(zh)
|
2013-03-15 |
2019-11-12 |
北卡罗来纳-查佩尔山大学 |
双重聚糖结合aav载体的方法和组合物
|
|
EP2999791B1
(en)
|
2013-05-21 |
2018-12-05 |
University of Florida Research Foundation, Inc. |
Capsid-modified, raav3 vector compositions and methods of use in gene therapy of human liver cancer
|
|
CA3209883A1
(en)
|
2013-07-22 |
2015-01-29 |
The Children's Hospital Of Philadelphia |
Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
LT3702466T
(lt)
|
2013-08-27 |
2023-02-27 |
Research Institute At Nationwide Children's Hospital |
Produktai ir būdai, skirti šoninės amiotrofinės sklerozės gydymui
|
|
ES2857751T3
(es)
|
2013-10-11 |
2021-09-29 |
Massachusetts Eye & Ear Infirmary |
Métodos para predecir secuencias de virus ancestrales y usos de los mismos
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
WO2015126972A1
(en)
|
2014-02-21 |
2015-08-27 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
|
US10308957B2
(en)
|
2014-03-04 |
2019-06-04 |
University Of Florida Research Foundation, Inc. |
rAAV vectors and methods for transduction of photoreceptors and RPE cells
|
|
DK3546585T3
(da)
|
2014-04-25 |
2025-11-03 |
Genethon |
Nukleinsyrer med en modificeret intron til brug i behandlingen af hyperbilirubinæmi
|
|
WO2015168666A2
(en)
|
2014-05-02 |
2015-11-05 |
Genzyme Corporation |
Aav vectors for retinal and cns gene therapy
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
BR112017010447A2
(pt)
|
2014-11-21 |
2018-05-15 |
The University Of North Carolina At Chapel Hill |
vetores de aav direcionados ao sistema nervoso central
|
|
GB201502137D0
(en)
|
2015-02-09 |
2015-03-25 |
Ucl Business Plc |
Treatment
|
|
WO2016133917A1
(en)
|
2015-02-16 |
2016-08-25 |
University Of Florida Research Foundation |
Raav vector compositions, methods for targeting vascular endothelial cells and use in treatment of type i diabetes
|
|
US20180245073A1
(en)
|
2015-02-23 |
2018-08-30 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
CN114480502A
(zh)
|
2015-03-02 |
2022-05-13 |
阿德夫拉姆生物技术股份有限公司 |
用于将多核苷酸玻璃体内递送到视网膜视锥的组合物和方法
|
|
WO2016154344A1
(en)
|
2015-03-24 |
2016-09-29 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
|
EP4491733A3
(en)
|
2015-04-23 |
2025-03-26 |
University of Massachusetts |
Modulation of aav vector transgene expression
|
|
GB201508026D0
(en)
*
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
HUE068603T2
(hu)
|
2015-06-23 |
2025-01-28 |
Childrens Hospital Philadelphia |
Módosított IX-es faktor, valamint készítmények, eljárások és alkalmazások sejtekbe, szervekbe és szövetekbe történõ géntranszferhez
|
|
WO2017015102A1
(en)
|
2015-07-17 |
2017-01-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for achieving high levels of transduction in human liver cells
|
|
US20190000940A1
(en)
|
2015-07-31 |
2019-01-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
|
JP7064214B2
(ja)
|
2015-09-28 |
2022-05-10 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
抗体回避性ウイルスベクターのための方法および組成物
|
|
WO2017066764A2
(en)
|
2015-10-16 |
2017-04-20 |
William Marsh Rice University |
Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
|
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
MX2018004755A
(es)
|
2015-10-29 |
2018-12-19 |
Voyager Therapeutics Inc |
Entrega de polinucleotidos dirigidos al sistema nervioso central.
|
|
PE20231949A1
(es)
|
2015-10-30 |
2023-12-05 |
Spark Therapeutics Inc |
VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA
|
|
RU2021102893A
(ru)
|
2015-11-05 |
2021-03-03 |
Бамбу Терапьютикс, Инк. |
Модифицированные гены атаксии фридрейха и векторы для генной терапии
|
|
US10406244B2
(en)
|
2015-12-02 |
2019-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
AAV vectors with expanded packaging capacity
|
|
EP3384034B1
(en)
|
2015-12-02 |
2020-07-08 |
The Board of Trustees of the Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
|
|
DK3387137T3
(da)
|
2015-12-11 |
2021-05-03 |
California Inst Of Techn |
Målretningspeptider til styring af adeno-associerede virusser (aav`er)
|
|
CN108602859B
(zh)
|
2015-12-14 |
2023-05-26 |
北卡罗来纳大学教堂山分校 |
增强细小病毒载体递送的修饰衣壳蛋白
|
|
WO2017143100A1
(en)
|
2016-02-16 |
2017-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
|
|
WO2017161273A1
(en)
|
2016-03-18 |
2017-09-21 |
The Children's Hospital Of Philadelphia |
Therapeutic for treatment of diseases including the central nervous system
|
|
US11433116B2
(en)
|
2016-04-14 |
2022-09-06 |
Cedars-Sinai Medical Center |
GJA1 isoforms protect against metabolic stress
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448875A4
(en)
|
2016-04-29 |
2020-04-08 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
AU2017267665C1
(en)
|
2016-05-18 |
2023-10-05 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
EP3472196B1
(en)
|
2016-06-16 |
2026-03-18 |
Charité - Universitätsmedizin Berlin |
Neuropeptide-expressing vectors and methods for the treatment of epilepsy
|
|
IL263801B2
(en)
|
2016-07-26 |
2024-01-01 |
Biomarin Pharm Inc |
Novel adeno-associated virus capsid proteins
|
|
US11698377B2
(en)
|
2016-08-15 |
2023-07-11 |
Genzyme Corporation |
Methods for detecting AAV
|
|
JP7610923B2
(ja)
|
2016-09-02 |
2025-01-09 |
スパーク セラピューティクス インコーポレイテッド |
Ｃｎｓ障害を治療するための方法及びベクター
|
|
EP3293203A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
IL299325B2
(en)
|
2016-09-12 |
2025-08-01 |
Inst Nat Sante Rech Med |
Acid-alpha glucosidase variants and uses thereof
|
|
EP3293259A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
US11578340B2
(en)
|
2016-10-13 |
2023-02-14 |
University Of Massachusetts |
AAV capsid designs
|
|
GB2607227B
(en)
|
2016-10-27 |
2023-05-10 |
Intima Bioscience Inc |
Viral methods of T cell therapy
|
|
AU2018221738B2
(en)
|
2017-02-15 |
2024-06-27 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for gene transfer across the vasculature
|
|
US11541131B2
(en)
|
2017-03-10 |
2023-01-03 |
Genethon |
Treatment of glycogen storage disease III
|
|
ES2966692T3
(es)
|
2017-03-15 |
2024-04-23 |
Univ North Carolina Chapel Hill |
Vectores de virus adenoasociados poliploides y métodos de fabricación y uso de los mismos
|
|
WO2018189244A1
(en)
|
2017-04-11 |
2018-10-18 |
Ruprecht-Karls-Universität Heidelberg |
Adeno-associated virus library
|
|
WO2018200419A1
(en)
|
2017-04-23 |
2018-11-01 |
The Trustees Of The University Of Pennsylvania |
Viral vectors comprising engineered aav capsids and compositions containing the same
|
|
CA3061652A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
CN111108198A
(zh)
|
2017-05-05 |
2020-05-05 |
沃雅戈治疗公司 |
治疗亨廷顿病的组合物和方法
|
|
AU2018281306B2
(en)
|
2017-06-07 |
2025-04-17 |
Spark Therapeutics, Inc. |
Enhancing agents for improved cell transfection and/or rAAV vector production
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
MX2020000216A
(es)
|
2017-06-30 |
2020-09-03 |
Spark Therapeutics Inc |
Metodos de purificacion por columna de vectores aav.
|
|
TWI820034B
(zh)
|
2017-07-31 |
2023-11-01 |
香港商映像生物有限公司 |
眼部疾病之細胞模式及用於眼部疾病的療法
|
|
BR112020001979A2
(pt)
|
2017-08-01 |
2020-08-18 |
Spark Therapeutics, Inc. |
métodos de terapia genética do fator viii (fviii)
|
|
WO2019028306A2
(en)
|
2017-08-03 |
2019-02-07 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR ADMINISTRATION OF ADENO-ASSOCIATED VIRUSES
|
|
CA3070040A1
(en)
|
2017-08-29 |
2019-03-07 |
Ruprecht-Karls-Universitat Heidelberg |
Rationally designed virus-like particles for modulation of chimeric antigen receptor (car)-t-cell therapy
|
|
US20200377887A1
(en)
|
2017-09-22 |
2020-12-03 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
|
EP3694998A1
(en)
|
2017-10-12 |
2020-08-19 |
Freeline Therapeutics Limited |
Life-cycle-defective adenovirus helper viruses, their production and use for producing raav
|